The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Bär & Karrer Ltd.

BRANDSCHENKESTRASSE 90, 8027 ZÜRICH, SWITZERLAND
Tel:
Work +41 58 261 50 00
Fax:
Fax 0041582635393
Email:
Web:
www.baerkarrer.ch
Geneva, Lugano, Zug, Zurich

Show all Press releases

Bär & Karrer Advises the Banking Syndicate in the IPO of Polyphor

May 2018

Polyphor Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative antibiotics and other specialty pharma products, successfully priced its IPO and listed its shares on the SIX Swiss Exchange. Trading in the shares started on 15 May 2018. The shares were priced at the upper end of the price range, resulting in gross proceeds of CHF 165 million. The IPO of Polyphor is considered the largest biotech IPO in Switzerland in over 10 years and one of the top three in Europe within the last three years in terms of proceeds raised by an issuer in order to finance the development of its pipeline.

UBS AG and Deutsche Bank are acting as joint global coordinators, Cantor Fitzgerald Europe and Cantonal Bank of Zurich as co-lead managers and Octavian as selling agent.

Bär & Karrer advises the syndicate banks in this transaction. The team includes Thomas U. Reutter, Daniel Raun, Alexander von Jeinsen and Stefanie Walch (all Capital Markets) as well as Christoph Suter and Cyrill Diefenbacher (both Tax).

Legal Developments by:
Bär & Karrer Ltd.

  • Bär & Karrer Advised the Issuer in the Rights Offering of Cavotec SA

    On 10 January 2019, Cavotec SA completed a capital increase by way of a rights offering to its shareholders in the amount of approximately CHF 22.4 million. The Cavotec group, with its Swiss holding company listed on Nasdaq Stockholm, is a leading engineering group that designs and manufactures automated connection and electrification systems for ports, airports and industrial applications worldwide. 80.5% of the shareholders of Cavotec SA exercised their subscription rights in the rights offering. The remaining new shares not subscribed were allotted to investors who had subscribed for shares without subscription rights, pursuant to the allocation procedure described in the prospectus of 6 December 2018. The offer price was set at SEK 13 per share.
    - Bär & Karrer

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to